Arie Belldegrun

Affiliations

  • at Allogene Therapeutics Inc. (ALLO), 2024-01-31
  • Director at Urogen Pharma Ltd. (URGN), 2023-09-08
  • Director at Kronos Bio Inc. (KRON), 2023-06-26
  • Director at Ginkgo Bioworks Holdings Inc. (DNA), 2023-06-21
  • Chairman, President And Ceo at Kite Pharma Inc. (KITE), 2017-10-06
  • Director at Arno Therapeutics Inc (ARNI), 2016-08-17
  • Director at Nile Therapeutics Inc. (NLTX), 2011-05-12
  • Director at Cougar Biotechnology Inc. (CGRB), 2009-07-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALLO $12.60 155,039 195,039 2022-01-12 Filing
ALLO $47.00 106,382 1,798,163 2020-06-04 Filing
ALLO $47.00 40,000 40,000 2020-06-04 Filing
ALLO $18.00 194,445 Director 1,691,781 2018-10-15 Filing
ALLO $18.00 35,000 Large Shareholder, Director 35,000 2018-10-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $179.66 26,347 Officer, Director 109,160 2017-09-25 Filing
KITE $50.86 3,493 Officer, Director 24,707 2016-12-20 Filing